$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—KZR, FORA, SLNO, and APLS

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

  • Kezar Life Sciences, Inc. (NASDAQ: 

    KZR

    related to its sale to Aurinia Pharmaceuticals Inc. Under the terms of the proposed transaction, Kezar shareholders are expected to receive $6.955 per share in cash and one non-transferable contingent value right.

ACT NOW. The Tender Offer expires on May 8, 2026.

Click here for more information

https://monteverdelaw.com/case/kezar-life-sciences-inc/

. It is free and there is no cost or obligation to you.

  • Forian Inc. (NASDAQ: 

    FORA

    related to its sale to a consortium led by Max Wygod, Chairman and Chief Executive Officer, together with certain other senior executives and existing shareholders of the company. Under the terms of the proposed transaction, Forian shareholders are expected to receive $2.17 per share in cash.

Click here for more information

https://monteverdelaw.com/case/forian-inc/

. It is free and there is no cost or obligation to you.

  • Soleno Therapeutics, Inc. (NASDAQ: 

    SLNO

    related to its sale to Neurocrine Biosciences, Inc. Under the terms of the proposed transaction, Soleno shareholders are expected to receive $53.00 per share in cash.

Click here for more information

https://monteverdelaw.com/case/soleno-therapeutics-inc/

. It is free and there is no cost or obligation to you.

  • Apellis Pharmaceuticals, Inc. (NASDAQ: 

    APLS

    related to its sale to Biogen, Inc. Under the terms of the proposed transaction, Apellis shareholders are expected to receive $41.00 per share in cash and a non-transferable contingent value right for the right to receive two payments of $2.00 per share each, contingent on certain annual global net sales thresholds being met for SYFOVRE.

ACT NOW. The Tender Offer expires on May 13, 2026.

Click here for more info

https://monteverdelaw.com/case/apellis-pharmaceuticals-inc/

.
It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

  1. Do you file class actions and go to Court?
  2. When was the last time you recovered money for shareholders?
  3. What cases did you recover money in and how much?

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.